Enovix (Enovix) Change In Other Working Capital : $-4.49 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Enovix Change In Other Working Capital?

Enovix's Change In Other Working Capital for the quarter that ended in Dec. 2023 was $-4.48 Mil. It means Enovix's Other Working Capital declined by $4.48 Mil from Sep. 2023 to Dec. 2023 .

Enovix's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-4.49 Mil. It means Enovix's Other Working Capital declined by $4.49 Mil from Dec. 2022 to Dec. 2023 .

Enovix Change In Other Working Capital Historical Data

The historical data trend for Enovix's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Change In Other Working Capital Chart

Enovix Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

-1.68

2.89

-4.14

-4.49

Enovix Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Other Working Capital	Get a 7-Day Free Trial									-3.58	-	0.01	-0.01	-4.48

Enovix Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.49 Mil.

Enovix Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Enovix's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Enovix (Enovix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

6Q81:Germany 6Q81:Germany

Address

3501 W. Warren Avenue, Fremont, CA, USA, 94538

Website

https://www.enovix.com

Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.

Executives

Rajendra K Talluri	director, officer: President and CEO	3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins	director
Arthi Chakravarthy	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad	officer: Chief Financial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann	director	ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers	director, 10 percent owner	535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri	officer: Chief Technology Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe	officer: Chief Operating Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust	director, officer: President and CEO	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p.	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie	director	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538